2022 - Research.com Best Scientist Award
His primary areas of study are Movement disorders, Dystonia, Parkinson's disease, Surgery and Central nervous system disease. His study in Movement disorders is interdisciplinary in nature, drawing from both Tics, Tetrabenazine, Chorea, Parkinsonism and Pediatrics. His Dystonia study combines topics from a wide range of disciplines, such as Anesthesia and Akathisia.
His work carried out in the field of Parkinson's disease brings together such families of science as Physical therapy and Severity of illness. Joseph Jankovic has researched Surgery in several fields, including Levodopa, Dyskinesia and Thalamotomy. His Central nervous system disease research incorporates themes from Dementia and Pathology.
Joseph Jankovic spends much of his time researching Parkinson's disease, Movement disorders, Dystonia, Internal medicine and Disease. His Parkinson's disease study often links to related topics such as Neuroscience. The study incorporates disciplines such as Physical medicine and rehabilitation, Chorea, Psychiatry, Physical therapy and Pediatrics in addition to Movement disorders.
His Dystonia study integrates concerns from other disciplines, such as Botulinum toxin, Anesthesia, Surgery and Neurological disorder. His research integrates issues of Gastroenterology and Endocrinology in his study of Internal medicine. His Disease research incorporates elements of Genetics and Intensive care medicine.
His primary scientific interests are in Movement disorders, Dystonia, Parkinson's disease, Disease and Physical medicine and rehabilitation. Joseph Jankovic interconnects Psychiatry, Tics, Psychogenic disease, Chorea and Pediatrics in the investigation of issues within Movement disorders. His research investigates the connection between Dystonia and topics such as Deep brain stimulation that intersect with issues in Levodopa.
Joseph Jankovic has included themes like Neuroscience, Pathogenesis and Bioinformatics in his Parkinson's disease study. His Disease research integrates issues from Genetics and Clinical trial. Joseph Jankovic combines subjects such as Internal medicine, Physical therapy and Spasmodic Torticollis with his study of Cervical dystonia.
His primary areas of investigation include Disease, Parkinson's disease, Movement disorders, Dystonia and Physical therapy. His Disease research is multidisciplinary, incorporating elements of Genetics, Gene, Clinical trial, Physical medicine and rehabilitation and Neurology. His Parkinson's disease research is multidisciplinary, relying on both Essential tremor, Stimulation, Neuroscience and Pathogenesis.
Joseph Jankovic regularly links together related areas like Blepharospasm in his Movement disorders studies. His work in Dystonia tackles topics such as Dyskinesia which are related to areas like Chorea and Pediatrics. His Physical therapy research is multidisciplinary, incorporating perspectives in Clinical Global Impression, Cervical dystonia, Internal medicine, Randomized controlled trial and Deutetrabenazine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Parkinson’s disease: clinical features and diagnosis
Journal of Neurology, Neurosurgery, and Psychiatry (2008)
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
Christopher G. Goetz;Barbara C. Tilley;Stephanie R. Shaftman;Glenn T. Stebbins.
Movement Disorders (2008)
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) Report of the NINDS-SPSP International Workshop*
I. Litvan;Y. Agid;D. Calne;G. Campbell.
Phenomenology and classification of dystonia: a consensus update.
Alberto Albanese;Kailash Bhatia;Susan B. Bressman;Mahlon R. DeLong.
Movement Disorders (2013)
Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy
I. J. Schatz;R. Bannister;R. L. Freeman;C. G. Goetz.
Variable expression of Parkinson's disease A base‐line analysis of the DAT ATOP cohort
Joseph Jankovic;Michael P McDermott;Jonathan T Carter;Susan A Gauthier.
Pramipexole vs Levodopa as initial treatment for Parkinson disease: A randomized controlled trial
R. Holloway;I. Shoulson;K. Kieburtz;M. McDermott.
Parkinson's Disease and Movement Disorders
Joseph Jankovic;Eduardo Tolosa.
European Journal of Neurology (2003)
THERAPEUTIC USES OF BOTULINUM TOXIN
Joseph Jankovic;Mitchell F. Brin.
The New England Journal of Medicine (1991)
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.
Christopher G. Goetz;Stanley Fahn;Pablo Martinez-Martin;Werner Poewe.
Movement Disorders (2007)
Expert Review of Neurotherapeutics
(Impact Factor: 4.287)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: